Double pancreatic and gastric adenocarcinomas: A rare association

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 6, 2013, Pages

  Kourie, Hampig Raphael ^a   Markoutsaki, Nina ^b   Roussel, Hélène ^a   Rahmi, Gabriel ^b   Van der Stiegel, Muriel ^a   Palazzo, Laurent ^a   Fabre, Monique ^a   Cuenod, Charles A ^b   Dubreuil, Olivier ^b   Landi, Bruno ^b   Rougier, Philippe ^b   Taieb, Julien ^b  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ACUTE PANCREATITIS; ADIPOSE TISSUE; ADULT; ARTICLE; CANCER DIAGNOSIS; CARCINOMATOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ENDOSCOPIC ECHOGRAPHY; HISTOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; RADIODENSITOMETRY; RARE DISEASE; RISK FACTOR; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; ORGANOPLATINUM COMPOUNDS; PANCREATIC NEOPLASMS; RARE DISEASES; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84888439127     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.09.008     Document Type: Article

References (15)

1. Naofumi E., Shigeaki A., Masao H., Koji O., Tsuyoshi T., Shuichi F., et al. Synchronous or metachronous double cancers of the pancreas and other organs: report on 12cases. Surg Today 2000, 30:718-721.
2. Irimie A., Achimas-Cadariu P., Burz C., Puscas E. Multiple primary malignancies-epidemiological analysis at a single tertiary institution. J Gastrointestin Liver Dis 2010, 19(1):69-73.
3. Minni F., Casadei R., Marrano N., Guerra E., Piccoli L., Pagogna S., et al. Second tumours in patients with malignant neoplasms of the digestive apparatus. A retrospective study on 2406cases. Ann Ital Chir 2005, 76(5):467-472.
4. Eriguchi N., Aoyagi S., Hara M., Okuda K., Tamae T., Fukuda S., et al. A case of synchronous double cancers of the pancreas and stomach. Kurume Med J 2000, 47:169-171.
5. Kubota E., Kataoka H., Hayashi K., Kamiya T., Sasaki M., Ogasawara N., et al. Advanced stomach and pancreas cancer successfully treated with combination chemotherapy with S-1/paclitaxel/lentinan. Hepatogastroenterology 2009, 56(89):106-110.
6. Muroni M., D'Angelo F., Pezzatini M., Sebastiani S., Noto S., Pilozzi E., et al. Synchronous gastric adenocarcinoma and pancreatic ductal adenocarcinoma. Hepatobiliary Pancreat Dis Int 2010, 9(1):97-99.
7. Robbins E.G., Franceschi D., Barkin J.S. Solitary metastatic tumors to the pancreas: a case report and review of the literature. Am J Gastroenterol 1996, 91:2414-2417.
8. Menuck L.S., Amberg J.R. Metastatic disease involving the stomach. Am J Dig Dis 1975, 20(10):903-913.
9. Tsiambas E., Karameris A., Dervenis C., Lazaris A.C., Giannakou N., Gerontopoulos K., et al. HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis. JOP 2006, 7(3):283-294.
10. Lee J.H., Bae J.S., Ryu K.W., Lee J.S., Park S.R., Kim C.G., et al. Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol 2006, 12(16):2588-2592.
11. Ikeguchi M., Ohfuji S., Oka A., Tsujitani S., Maeda M., Kaibara N. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer. Hepatogastroenterology 1995, 42(5):672-676.
12. Makino T., Konishi Y., Takahashi S., Maruyama H., Kohara T., Yokose Y., et al. Clinicopathology of pancreatic cancer analyzed from annual of the pathological autopsy cases in Japan (in Japanese). Tan To Sui (J Gall Pancr) 1984, 5:761-768.
13. Goggins M., Offerhaus G.J., Hilgers W., et al. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 1998, 152(6):1501-1507.
14. Conroy T., Desseigne F., Ychou M., Bouché O., Guimbaud R., Bécouarn Y., et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011, 364(19):1817-1825.
15. Lee J., Kang W.K., Kwon J.M., Oh S.Y., Lee H.R., Kim H.J., et al. Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma. Ann Oncol 2007, 18(1):88-92.